Wells Fargo & Company »

Halozyme Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2012-06-30 $2.9M 327k 8.86
2011-09-30 $2.0M 319k 6.14
2011-03-31 $20M 3.0M 6.75
2010-12-31 $706k 89k 7.91